Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders.
Defrancesco I, Visentini M, Zibellini S, Minafò YA, Rattotti S, Ferretti VV, Rizzo E, Varettoni M, Frigeni M, Pulsoni A, Casato M, Colantuono S, Rossi M, Candido C, Zerbi C, Bergamini F, Cristinelli C, Fabbri N, Merli M, Zuccaro V, Bruno R, Paulli M, Arcaini L. Defrancesco I, et al. Among authors: colantuono s. Am J Hematol. 2021 Jun 1;96(6):E210-E214. doi: 10.1002/ajh.26167. Epub 2021 Apr 9. Am J Hematol. 2021. PMID: 33755245 Free PMC article. No abstract available.
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection.
Visentini M, Ludovisi S, Petrarca A, Pulvirenti F, Zaramella M, Monti M, Conti V, Ranieri J, Colantuono S, Fognani E, Piluso A, Tinelli C, Zignego AL, Mondelli MU, Fiorilli M, Casato M. Visentini M, et al. Among authors: colantuono s. Autoimmun Rev. 2011 Sep;10(11):714-9. doi: 10.1016/j.autrev.2011.04.033. Epub 2011 May 5. Autoimmun Rev. 2011. PMID: 21570494 Clinical Trial.
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review.
Visentini M, Tinelli C, Colantuono S, Monti M, Ludovisi S, Gragnani L, Mitrevski M, Ranieri J, Fognani E, Piluso A, Granata M, De Silvestri A, Scotti V, Mondelli MU, Zignego AL, Fiorilli M, Casato M. Visentini M, et al. Among authors: colantuono s. Autoimmun Rev. 2015 Oct;14(10):889-96. doi: 10.1016/j.autrev.2015.05.013. Epub 2015 May 29. Autoimmun Rev. 2015. PMID: 26031898 Clinical Trial.
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.
Gragnani L, Visentini M, Fognani E, Urraro T, De Santis A, Petraccia L, Perez M, Ceccotti G, Colantuono S, Mitrevski M, Stasi C, Del Padre M, Monti M, Gianni E, Pulsoni A, Fiorilli M, Casato M, Zignego AL. Gragnani L, et al. Among authors: colantuono s. Hepatology. 2016 Nov;64(5):1473-1482. doi: 10.1002/hep.28753. Epub 2016 Aug 29. Hepatology. 2016. PMID: 27483451
Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis.
Visentini M, Del Padre M, Colantuono S, Yang B, Minafò YA, Antonini S, Carnovale M, De Santis A, Pulsoni A, De Sanctis GM, Gragnani L, Zignego AL, Fiorilli M, Casato M. Visentini M, et al. Among authors: colantuono s. Liver Int. 2019 Apr;39(4):628-632. doi: 10.1111/liv.14053. Epub 2019 Feb 15. Liver Int. 2019. PMID: 30690862
50 results